BIFROST BIOSYSTEMS INC — Department of Defense SBIR Phase II: HR001121S0007-28

BIFROST BIOSYSTEMS INC — SBIR Phase II award from Department of Defense.

Phase II SBIR prototype / development signal

  • Phase II is where Department of Defense funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
  • Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
  • At $2,968,910, this is a large obligation for typical SBIR Phase sizing — worth reviewing for scope breadth and teaming opportunity.
  • Tagged technology areas: Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
  • Topic code HR001121S0007-28 links this award to a solicitation family — search the same topic stem for incumbents and recompete timing.

Informational capture context from public federal data — not legal or bid advice.

Summary

Bifrost Biosystems Inc received nearly $3 million from DARPA to develop a high-throughput system for tracking cell lineages. This technology aims to speed up bioengineering processes and improve pathogen detection.

Amount
$2,968,910
Agency
Department of Defense · Defense Advanced Research Projects Agency
Program / Phase
SBIR · Phase II
Topic
HR001121S0007-28
Solicitation
HR001121S0007.I
NAICS
541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
Place of performance
CA
Period
2023-05-22 → 2027-11-30

Technology domains

Human Performance & Medical

Description

PHASE II SBIR ROBUST OPERATIONAL ULTRA-HIGH THROUGHPUT CELL LINEAGE TRACKING FOR RAPID BIOENGINEERING AND PATHOGEN DETECTION

View on USASpending.gov ↗